Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experiments

Introduction Proton pump inhibitors (PPIs) are widely prescribed for gastrointestinal disorders and are often used empirically in patients with pancreatic disease, yet their long-term impact on pancreatic health remains unclear. We evaluated whether regular PPI use is associated with risks of acute...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Xin Gao, Zouhua Xu, Qingxie Liu, Chenchen Yuan, Xiaowu Dong, Xiaolei Shi, Qingtian Zhu, Keyan Wu, Hongwei Xu, Jiajia Pan, Guotao Lu, Weiming Xiao, Shengfeng Wang, Yaodong Wang
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2025-10-01
سلاسل:	Frontiers in Pharmacology
الموضوعات:	proton pump inhibitors pancreatic disease incidence drug safety prospective cohort health sciences
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1673200/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!